Grant Directory
Browse every open and forecasted federal, state, and foundation grant in the GrantRegister directory.
2,545open & forecasted grants · page 19 of 54
Federal Agency · National Institutes of Health
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Funding amount not specified·Closes November 16, 2027
Federal Agency · National Institutes of Health
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Up to $200K·Closes November 16, 2027
Federal Agency · National Institutes of Health
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Up to $100K·Closes November 16, 2027
Federal Agency · National Institutes of Health
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
Funding amount not specified·Closes November 16, 2027
Federal Agency · National Institutes of Health
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Up to $300K·Closes November 18, 2027
Federal Agency · Dept of the Army -- Materiel Command
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Funding amount not specified·Closes November 20, 2027
Federal Agency · National Institutes of Health
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Funding amount not specified·Closes December 3, 2027
Federal Agency · National Institutes of Health
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Funding amount not specified·Closes December 3, 2027
Federal Agency · National Institutes of Health
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Up to $350K·Closes December 23, 2027
Federal Agency · National Institutes of Health
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Funding amount not specified·Closes December 23, 2027
Federal Agency · National Institutes of Health
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Funding amount not specified·Closes December 23, 2027
Federal Agency · National Institutes of Health
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Funding amount not specified·Closes December 23, 2027
Federal Agency · National Institutes of Health
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Funding amount not specified·Closes December 23, 2027
Federal Agency · National Park Service
NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
$0·Closes December 31, 2027
Federal Agency · Dept of the Army -- Materiel Command
DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Funding amount not specified·Closes January 4, 2028
Federal Agency · National Institutes of Health
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Funding amount not specified·Closes January 6, 2028
Federal Agency · National Institutes of Health
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Up to $500K·Closes January 6, 2028
Federal Agency · National Institutes of Health
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Funding amount not specified·Closes January 6, 2028
Federal Agency · National Institutes of Health
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 6, 2028
Federal Agency · National Institutes of Health
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
Up to $499K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
Up to $499K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
Up to $375K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Up to $200K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
Up to $150K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
Up to $225K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Up to $500K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Up to $75K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Up to $500K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
Federal Agency · National Institutes of Health
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Up to $500K·Closes January 7, 2028
Federal Agency · National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Funding amount not specified·Closes January 7, 2028
GrantRegister provides information, not advice. Eligibility requirements and deadlines are set by the funder and can change without notice. Confirm eligibility, deadlines, and requirements with the issuing organization before applying.